India's Bharat Biotech offers Brazil potential COVID-19 vaccine

The private pharmaceutical company based in the southern city of Hyderabad is developing a whole-virion inactivated vaccine called Covaxin that could be licensed by the second quarter of 2021.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news